Cross Country Healthcare Inc. (CCRN) intrinsic value & 10-year financials
Cross Country Healthcare Inc. (CCRN) has a Graham intrinsic value of $24.37 per share. Over the last 10 fiscal years revenue grew 2.6% a year to $1.1B, with an average return on invested capital of 4.9%.
- Graham intrinsic value
- $24.37
- Revenue (FY2025)
- $1.1B
- Revenue growth (10-yr CAGR)
- 2.6%
- ROIC (10-yr avg)
- 4.9%
- Free cash flow (FY2025)
- $40.1M
CCRN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.1B | -$94.9M | -$2.93 | $40.1M | -8.0% | -30.5% |
| FY2024 | $1.3B | -$14.6M | -$0.44 | $111.4M | -1.3% | -3.8% |
| FY2023 | $2.0B | $72.6M | $2.05 | $234.5M | 5.6% | 14.9% |
| FY2022 | $2.8B | $188.5M | $5.02 | $125.3M | 9.7% | 36.4% |
| FY2021 | $1.7B | $132.0M | $3.53 | -$92.8M | 8.3% | 38.4% |
| FY2020 | $836.4M | -$13.0M | -$0.36 | $22.6M | -1.1% | -3.8% |
| FY2019 | $822.2M | -$57.7M | -$1.61 | $2.6M | -1.9% | -5.9% |
| FY2018 | $816.5M | -$17.0M | -$0.48 | $16.4M | -1.6% | -3.8% |
| FY2017 | $865.0M | $37.5M | $1.01 | $40.4M | 1.4% | 4.4% |
| FY2016 | $833.5M | $8.0M | $0.15 | $23.6M | 0.7% | 2.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CROSS COUNTRY HEALTHCARE INC has demonstrated mature, steady growth, with revenue compounding at 2.6% annually over the past decade.
CROSS COUNTRY HEALTHCARE INC has historically struggled to out-earn its cost of capital, averaging just 4.9% ROIC.
Over the decade, CROSS COUNTRY HEALTHCARE INC shows that management has aggressively returned capital to shareholders by retiring 10.6% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CROSS COUNTRY HEALTHCARE INC is modeled at 2.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $24.37 per share.